Taysha Gene Therapies Inc (TSHA)
2.57
-0.01
(-0.39%)
USD |
NASDAQ |
May 03, 16:00
2.575
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Revenue (TTM): 15.45M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 15.45M |
Date | Value |
---|---|
September 30, 2023 | 14.35M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.35M
Minimum
Sep 2023
15.45M
Maximum
Dec 2023
14.90M
Average
14.90M
Median
Revenue (TTM) Benchmarks
Aquestive Therapeutics Inc | 50.58M |
Lifecore Biomedical Inc | 141.30M |
Relmada Therapeutics Inc | -- |
ACADIA Pharmaceuticals Inc | 726.44M |
Cyclacel Pharmaceuticals Inc | -- |